Intellectual Property

  • September 30, 2024

    Generic-Drug Co. Says To Think Again About 'Double Patenting'

    An Indian generic-drug maker wants the whole Federal Court to take a closer look at the issue of "double patenting," telling it that a recent panel ruling mistakenly breathed new life into pharmaceutical patents covering an anti-diarrhea drug.

  • September 30, 2024

    9th Circ. Asked To Interpret DMCA In GitHub Code Suit

    A California federal court has asked the Ninth Circuit to determine if the Digital Millennium Copyright Act requires an infringing copy be identical to the original to have an actionable claim for removing copyright management information, a key question in a case where developers sued Microsoft and GitHub for allegedly ripping off code to develop AI tools.

  • September 30, 2024

    Atari Can Pursue Copyright Claim Against State Farm Over Ad

    Atari Interactive Inc. can pursue a copyright infringement claim against State Farm Mutual Automobile Insurance Co. because the insurer featured part of the 1980s arcade game Crystal Castles in a commercial, but a Texas federal judge tossed all the other claims in the suit from the pioneering game company.

  • September 30, 2024

    BakerHostetler Says Ethics Suit Must Stay In Ga. Fed. Court

    BakerHostetler has asked a Georgia federal court not to remand a suit alleging the firm botched a patent application for a smart wardrobe system to state court, arguing that its former client's claims that the firm violated professional rules under U.S. patent law belong in federal court.

  • September 30, 2024

    Medical Device Co. Wins $25M Verdict In Poaching Trial

    Medical device company Cynosure won a $25 million jury award following a weekslong trial in Massachusetts federal court on its claims that a rival business raided its sales and marketing talent and caused the employees to breach their noncompete and nonsolicitation agreements.

  • September 30, 2024

    J&J Exec Accused Of File Heist Wants Pause Amid DOJ Case

    A former competitive strategy director for Johnson & Johnson accused of stealing confidential files as he left the company to work for Pfizer asked a New Jersey federal court to pause the suit after learning he is under criminal investigation.

  • September 27, 2024

    7th Circ. Doubts Artist Proved French Montana Copied Work

    Two Seventh Circuit judges seemed unsure Friday that they saw enough evidence of copying to reverse rapper French Montana's summary judgment win over claims that he infringed a California producer's sound recording copyright to make his song "Ain't Worried About Nothin'."

  • September 27, 2024

    IBM Owes $19.5M In EDTX Trial Over 'Blockchain' Software

    A Texas federal jury told IBM on Friday that its blockchain software infringes two patents by a small tech developer and that it owes $19.5 million, far less than the $167 million the developer asked for.

  • September 27, 2024

    FCC Chief Quotes Taylor Swift In Tough Stance On Deepfakes

    Federal Communications Commission chairwoman Jessica Rosenworcel vowed during a speech Friday to take a strong position on enforcing the Telephone Consumer Protection Act against AI-generated robocalls and noted the FCC is considering new AI election-related disclosure regulations, quoting pop singer Taylor Swift who said, "The simplest way to combat misinformation is with the truth."

  • September 27, 2024

    Fla. Timeshare Biz Wins $1.3M Fee Award In False Ad Suit

    A Florida federal judge has awarded more than $1.3 million in attorney fees to a timeshare company that prevailed in a lawsuit against a Wyoming company over a false advertising scheme encouraging customers to stop paying for their properties, after agreeing the marketers pursued an "exceptionally weak case" that would not succeed.

  • September 27, 2024

    Kappos' Bayh-Dole Warning To Clients Draws Debate

    An advocate for lowering drug prices squared off Friday against a former U.S. Patent and Trademark Office director about the potential risk of accepting government funds to develop drugs, as part of a discussion at New York University School of Law.

  • September 27, 2024

    Western Digital Wants $262M Patent Verdict Thrown Out

    Western Digital has asked a California federal court to either toss a jury's $262 million verdict against it and rule that the hard drive maker did not infringe any MR Technologies patents, or order a new trial in the dispute over technology that increases storage capacity of disk drives.

  • September 27, 2024

    Sen. Says Contractors Trying To Block DOD 'Right-To-Repair'

    Sen. Elizabeth Warren, D-Mass., has chided defense contractors for seeking to "sabotage" efforts to require them to cough up parts and data allowing the U.S. Department of Defense to repair its own equipment, while urging the DOD to take action on related restrictions.

  • September 27, 2024

    NC Biz Court Trims Pot Farm Fight With 'Amazon Of Hemp'

    An online hemp retailer has narrowed a North Carolina farm's lawsuit alleging the retailer doctored its THC reports before listing the farm's products for sale online, with a state Business Court judge finding they aren't competitors and the farm otherwise failed to show the retailer tried to pass off the hemp producer's products as its own.

  • September 27, 2024

    Disney Calls Writer's 'Moana' Copyright Theft Suit Pure Fiction

    Lawyers for The Walt Disney Co. urged a California federal judge Friday to throw out an animator and writer's lawsuit alleging the company stole his ideas for the hit movie "Moana," saying there's not a single piece of evidence meriting a jury trial.

  • September 27, 2024

    NRA, RNC Dropped From Isaac Hayes' IP Suit Against Trump

    The estate of legendary soul singer Isaac Hayes agreed Friday to voluntarily dismiss three defendants from a copyright complaint alleging former President Donald Trump has been playing the Hayes-penned song "Hold On, I'm Comin'" at campaign events without permission.

  • September 27, 2024

    Why Many Drugs Remain Pricey 40 Years After Hatch-Waxman

    In the four decades since Congress passed the Hatch-Waxman Act in an effort to make generic drugs more available, the pharmaceutical industry has used patent thickets, "evergreening" and pay-for-delay tactics to block competition and keep prices of life-saving specialty drugs astronomical, several legal experts told Law360, while the industry argues other parties shoulder more of the blame.

  • September 27, 2024

    Waco Jury Sticks ASUSTeK With $22M Patent Verdict

    A Texas federal jury hit Taiwanese computer manufacturer ASUSTeK Computer Inc. with a $22 million judgment on Thursday for infringing patents for a film that redirects natural daylight owned by SVV Technology Innovations Inc., which had asked jurors for nearly $59 million.

  • September 27, 2024

    Pharma Co. Amarin Beats Class Action Over Patent Issues

    A New Jersey federal judge has tossed a proposed class action against pharmaceutical company Amarin and its top brass, alleging they misled shareholders about their products and the prospects of related patent litigation, saying the investors have failed to plead any actionable misleading statements or omissions made by the defendants.

  • September 27, 2024

    Tattoo Artist's $3,750 Award Scrapped In Video Game IP Row

    An Illinois federal judge scrapped a $3,750 damages award for a former tattoo artist who sued World Wrestling Entertainment and two video game companies for depicting her tattoos on a wrestler without permission, saying the jury's award was based on undue speculation.

  • September 27, 2024

    Amazon Hit With $30.5M Verdict In Delaware Patent Trial

    A Delaware federal jury decided Friday that Amazon Web Services infringed two computer network patents that were once owned by Boeing, and told the tech giant to pay $30.5 million in damages.

  • September 27, 2024

    Off The Bench: College Sports Dominates Legal Landscape

    In this week's Off The Bench, the NCAA and the athletes in the big name, image and likeness settlement try to redo the terms to satisfy the overseeing judge, Reggie Bush says his image has been exploited by his alma mater and the NCAA for years, and the Pac-12 claims that it's being strong-armed by a rival conference for coaxing away its teams.

  • September 27, 2024

    Super Babies Cancel DC Comics, Marvel's 'Super Hero' TM

    The U.S. Patent and Trademark Office has canceled DC Comics and Marvel Characters Inc.'s jointly owned trademarks for "super hero" and variations of the term after a U.K.-based business that creates stories of super hero babies argued the term is generic and has been abandoned by DC Comics and Marvel.

  • September 27, 2024

    Valve Corp. May Continue Wash. 'Patent Troll' Claims

    Video game patent holder Leigh Rothschild, his company Rothschild Broadcast Distribution Systems LLC and his legal team from Meyler Legal PLLC cannot escape a federal suit alleging they violated the state of Washington's anti-troll laws in pursuing bogus patent claims against video game maker and online game store operator Valve Corp.

  • September 27, 2024

    Nike's Conduct In TM Battle Warrants Atty Fees, Report Says

    Sportswear giant Nike Inc.'s behavior and threats against a Pennsylvania apparel company during a trademark dispute are severe enough to support ordering Nike to pay attorney fees, a special master has said.

Expert Analysis

  • Allergan Ruling Reinforces Value Of Patent Term Adjustments

    Author Photo

    The Federal Circuit’s recent ruling in Allergan v. MSN, which held that patent term adjustment awards for first-filed, first-issued patents cannot be stripped away by later-issuing child patents that expire earlier, means practitioners must consider the potential impact of any action that might reduce the adjustment amount, say attorneys at Cooley.

  • Opinion

    AI May Limit Key Learning Opportunities For Young Attorneys

    Author Photo

    The thing that’s so powerful about artificial intelligence is also what’s most scary about it — its ability to detect patterns may curtail young attorneys’ chance to practice the lower-level work of managing cases, preventing them from ever honing the pattern recognition skills that undergird creative lawyering, says Sarah Murray at Trialcraft.

  • A Look At How De Minimis Import Rules May Soon Change

    Author Photo

    The planned implementation of executive actions focused on the de minimis rule as it applies to shipments means companies should use this interval to evaluate the potential applicability and impact of Section 301, Section 201 or Section 232 duties on their products, say attorneys at Holland & Knight.

  • How To Craft Strong Prong 2 Arguments For AI Patent Apps

    Author Photo

    The U.S. Patent and Trademark Office’s recent guidance update on subject matter eligibility for artificial intelligence inventions highlights that the key to overcoming rejection lies in the analysis under Prong 2, which practitioners should consider leading their arguments with, says Sean Lee at Baker Botts.

  • IP Concerns For Manufacturing Semiconductors In Low Orbit

    Author Photo

    With space habitation companies working to launch private space stations in the near future, semiconductor manufacturers aiming to execute research and development in low or microgravity must consider the unique claim drafting and patent protection issues that will emerge, says Greg Miraglia at Quinn Emanuel.

  • 6 Tips For Trying Cases Away From Home

    Excerpt from Practical Guidance
    Author Photo

    A truly national litigation practice, by definition, often requires trying cases in jurisdictions across the country, which presents unique challenges that require methodical preparation and coordination both within the trial team and externally, say Edward Bennett and Suzanne Salgado at Williams & Connolly.

  • 3 Coverage Tips As 2nd Circ. 'Swipes Left' On Tinder Claim

    Author Photo

    The Second Circuit's recent opinion in Match Group v. Beazley Underwriting, overturning Tinder's victory on its insurer's motion to dismiss a coverage action, reinforces three best practices policyholders purchasing claims-made coverage should adhere to in order to avoid late-notice defenses, say Lynda Bennett and Alexander Corson at Lowenstein Sandler.

  • USPTO Guidance Suggests 2 Strategies For AI Inventions

    Author Photo

    Analyzing the U.S. Patent and Trademark Office's recent guidance, it appears that there are at least two paths for establishing that an artificial intelligence invention is eligible for protection, and that which strategy to use may turn on how broadly the invention is applied, says William Morriss at Frost Brown.

  • A Blueprint For Structuring An Effective Plaintiff Case Story

    Author Photo

    The number and size of nuclear verdicts continue to rise, in part because plaintiffs attorneys have become more adept at crafting compelling trial stories — and an analysis of these success stories reveals a 10-part framework for structuring an effective case narrative, says Jonathan Ross at Decision Analysis.

  • Series

    Round-Canopy Parachuting Makes Me A Better Lawyer

    Author Photo

    Similar to the practice of law, jumping from an in-flight airplane with nothing but training and a few yards of parachute silk is a demanding and stressful endeavor, and the experience has bolstered my legal practice by enhancing my focus, teamwork skills and sense of perspective, says Thomas Salerno at Stinson.

  • And Now A Word From The Panel: The MDL Map

    Author Photo

    An intriguing yet unpredictable facet of multidistrict litigation practice is venue selection for new MDL proceedings, and the Judicial Panel on Multidistrict Litigation considers many factors when it assigns an MDL venue, says Alan Rothman at Sidley Austin.

  • Boeing Ruling Is A Cautionary Tale For Trade Secret Litigants

    Author Photo

    A Washington federal court’s recent ruling canceling a $72 million jury award against Boeing because Zunum Aero had failed to properly identify its trade secrets highlights the value of an early statement of alleged secrets, amended through discovery and used as a framework at trial, says Matthew D'Amore at Cornell.

  • Why Now Is The Time For Law Firms To Hire Lateral Partners

    Author Photo

    Partner and associate mobility data from the second quarter of this year suggest that there's never been a better time in recent years for law firms to hire lateral candidates, particularly experienced partners — though this necessitates an understanding of potential red flags, say Julie Henson and Greg Hamman at Decipher Investigative Intelligence.

  • Series

    After Chevron: Courts Will Still Defer To Feds On Nat'l Security

    Author Photo

    Agencies with trade responsibilities may be less affected by Chevron’s demise because of the special deference courts have shown when hearing international trade cases involving national security, foreign policy or the president’s constitutional authority to direct such matters, say attorneys at Venable.

  • A Look At The Economic Impact Of Drug Patent Differentiation

    Author Photo

    Given the Federal Trade Commission’s recent emphasis on unfair competition based on disputed patent listings, pharmaceutical market participants are likely to require nuanced characterizations of actual and but-for market competition when multiple patents differentiate multiple products, say economists at Competition Dynamics.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!